Member Exclusive

Cell therapy weekly: Roche acquires MS program and GvHD therapy receives Orphan Drug Designation

This week: Cynata's CYP-001 receives Orphan Drug Designation and Phase III disc degeneration trial completes enrollment.

Go to the profile of RegMedNet
Apr 05, 2018
0
0

Please sign in or register for FREE

Register to RegMedNet

RegMedNet is a free content and networking hub promoting global connection, knowledge-sharing and collaboration between all members of the regenerative medicine field.

Register

No comments yet.